Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361954089> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W4361954089 abstract "<div>Abstract<p>Platelet-derived growth factor (PDGF) receptor (PDGFR) expression correlates with metastatic medulloblastoma. PDGF stimulation of medulloblastoma cells phosphorylates extracellular signal-regulated kinase (ERK) and promotes migration. We sought to determine whether blocking PDGFR activity effectively inhibits signaling required for medulloblastoma cell migration and invasion. DAOY and D556 human medulloblastoma cells were treated with imatinib mesylate (Gleevec), a PDGFR tyrosine kinase inhibitor, or transfected with small interfering RNA (siRNA) to PDGFRB to test the effects of blocking PDGFR phosphorylation and expression, respectively. PDGFR cell signaling, migration, invasion, survival, and proliferation following PDGF-BB stimulation, with and without PDGFR inhibition, were measured. PDGF-BB treatment of cells increased PDGFRB, Akt and ERK phosphorylation, and transactivated epidermal growth factor receptor (EGFR), which correlated with enhanced migration, survival, and proliferation. Imatinib (1 μmol/L) treatment of DAOY and D556 cells inhibited PDGF-BB- and serum-mediated migration and invasion at 24 and 48 h, respectively, and concomitantly inhibited PDGF-BB activation of PDGFRB, Akt, and ERK but increased PTEN expression and activity. Imatinib treatment also induced DAOY cell apoptosis at 72 h and inhibited DAOY and D556 cell proliferation at 48 h. siRNA silencing of PDGFRB similarly inhibited signaling, migration, and survival and both siRNA and imatinib treatment inhibited PDGF-BB-mediated EGFR transactivation, indicating that the effects of imatinib treatment are specific to PDGFRB target inhibition. These results indicate that PDGFRB tyrosine kinase activity is critical for migration and invasion of medulloblastoma cells possibly by transactivating EGFR; thus, imatinib may represent an important novel therapeutic agent for the treatment of medulloblastoma. [Mol Cancer Ther 2009;8(5):1137–47]</p></div>" @default.
- W4361954089 created "2023-04-05" @default.
- W4361954089 creator A5006048639 @default.
- W4361954089 creator A5071668333 @default.
- W4361954089 date "2023-03-31" @default.
- W4361954089 modified "2023-09-26" @default.
- W4361954089 title "Data from Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor" @default.
- W4361954089 doi "https://doi.org/10.1158/1535-7163.c.6531954.v1" @default.
- W4361954089 hasPublicationYear "2023" @default.
- W4361954089 type Work @default.
- W4361954089 citedByCount "0" @default.
- W4361954089 crossrefType "posted-content" @default.
- W4361954089 hasAuthorship W4361954089A5006048639 @default.
- W4361954089 hasAuthorship W4361954089A5071668333 @default.
- W4361954089 hasBestOaLocation W43619540892 @default.
- W4361954089 hasConcept C104317684 @default.
- W4361954089 hasConcept C1292079 @default.
- W4361954089 hasConcept C170493617 @default.
- W4361954089 hasConcept C180361614 @default.
- W4361954089 hasConcept C185592680 @default.
- W4361954089 hasConcept C26375932 @default.
- W4361954089 hasConcept C2775960820 @default.
- W4361954089 hasConcept C42362537 @default.
- W4361954089 hasConcept C502942594 @default.
- W4361954089 hasConcept C55493867 @default.
- W4361954089 hasConcept C57074206 @default.
- W4361954089 hasConcept C62478195 @default.
- W4361954089 hasConcept C75217442 @default.
- W4361954089 hasConcept C78221974 @default.
- W4361954089 hasConcept C86339819 @default.
- W4361954089 hasConcept C86803240 @default.
- W4361954089 hasConcept C95444343 @default.
- W4361954089 hasConceptScore W4361954089C104317684 @default.
- W4361954089 hasConceptScore W4361954089C1292079 @default.
- W4361954089 hasConceptScore W4361954089C170493617 @default.
- W4361954089 hasConceptScore W4361954089C180361614 @default.
- W4361954089 hasConceptScore W4361954089C185592680 @default.
- W4361954089 hasConceptScore W4361954089C26375932 @default.
- W4361954089 hasConceptScore W4361954089C2775960820 @default.
- W4361954089 hasConceptScore W4361954089C42362537 @default.
- W4361954089 hasConceptScore W4361954089C502942594 @default.
- W4361954089 hasConceptScore W4361954089C55493867 @default.
- W4361954089 hasConceptScore W4361954089C57074206 @default.
- W4361954089 hasConceptScore W4361954089C62478195 @default.
- W4361954089 hasConceptScore W4361954089C75217442 @default.
- W4361954089 hasConceptScore W4361954089C78221974 @default.
- W4361954089 hasConceptScore W4361954089C86339819 @default.
- W4361954089 hasConceptScore W4361954089C86803240 @default.
- W4361954089 hasConceptScore W4361954089C95444343 @default.
- W4361954089 hasLocation W43619540891 @default.
- W4361954089 hasLocation W43619540892 @default.
- W4361954089 hasOpenAccess W4361954089 @default.
- W4361954089 hasPrimaryLocation W43619540891 @default.
- W4361954089 hasRelatedWork W2021537183 @default.
- W4361954089 hasRelatedWork W2104788151 @default.
- W4361954089 hasRelatedWork W2148476801 @default.
- W4361954089 hasRelatedWork W2160253516 @default.
- W4361954089 hasRelatedWork W2315114303 @default.
- W4361954089 hasRelatedWork W2320824175 @default.
- W4361954089 hasRelatedWork W2362447271 @default.
- W4361954089 hasRelatedWork W2579855430 @default.
- W4361954089 hasRelatedWork W30746305 @default.
- W4361954089 hasRelatedWork W3119141340 @default.
- W4361954089 isParatext "false" @default.
- W4361954089 isRetracted "false" @default.
- W4361954089 workType "article" @default.